Cite
HARVARD Citation
Charnigo, R. et al. (2019). PF‐04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo‐Controlled Study. Clinical and translational science. 12 (2), pp. 180-188. [Online].